drugset
drugset / Trial / NCT02711358

Indomethacin Use in Pain Relief During Intrauterine Device Insertion

NCT02711358 ↗

Phase 4 Completed 120 enrolled Assiut University
RandomizedParallel-groupTriple-blindPrevention

Summary

The aim of the investigators study is to test the analgesic effect of rectal indomethacin during Intrauterine device insertion.

Timeline

Start
2016-03
Primary completion
2016-07
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Indomethacin Small molecule 50 mg Rectal

Indications

No indication recorded.